1995Journal of Chinese Pharmaceutical SciencesRequires access

Protective effect of Phytolacca acinosa polysaccharides I (PAP-I) on hematopoiesis in cyclophosphamide-treated and ~(6))Co-irradiated mice

Hongbin Wang, Qin-Yue Zheng, Shengchuan Sun, Liu Bao-yun, Youan Shen, Huilan Tang, Dianwen Ju, Jun Fang

Open publisher page 0 citations

Abstract

Average survival time of mice treated with cyclophosphamide (CY)300mg/kg once alone was 13.3±7.2d(n=7), however, averge survival time of mice treated with CY 300 mg/kg in combination with PAP-1,10mg/kg, 3time/wk was 36.7±16.4d(n=7,P<0.01). PAP-1, ip had beneficial effect on the recovery of the CY induced decrease of peripheral leukocyte number, and the nucleated bone marrow cell (BMC) number and [~(3)H]TdR uptaken by BMC induced by rmGM-CSF in S180 bearing mice treated with CY, In mice, after the first ip treatment with CY 100mg/kg on d 7, the peripheral leukocyte number decreased on d9 and recovered to normal level about d13 to d15. Such recovery was accelerated by administrating PAP-1, 10mg/kg, 3 times/wk. A significant increase of the activity to form colony in spleen(colony-forming unit in spleen, CFU-S_(8), CUF-S_(12))in mice irradiated with 550 rad ~(Co) gamma-rays and an enhancement of proliferative response of BMC to rmGM-CSF treated with PAP-1, 10mg/kg, 3 times/wk, ip were observed. After PAP-1, 10mg/kg, ip once, a significant increase in the number of peripheral blood leukocytes and a rise in the serum of colony stimulating factor (CSF) were also confirmed. The types of CSF in serum were M-CSF and other hematopoietic growth factors, which were confirmed by using McAb of IL-3, GM-CSF and PcAb of M-CSF.

About this research paper

What this paper is about

Average survival time of mice treated with cyclophosphamide (CY)300mg/kg once alone was 13.3±7.2d(n=7), however, averge survival time of mice treated with CY 300 mg/kg in combination with PAP-1,10mg/kg, 3time/wk was 36.7±16.4d(n=7,P<0.01). PAP-1, ip had beneficial effect on the recovery of the CY induced decrease of peripheral leukocyte number, and the nucleated bone marrow cell (BMC) number and [~(3)H]TdR uptaken by BMC induced by rmGM-CSF in S180 bearing mice treated with CY, In mice, after the first ip treatment with CY 100mg/kg on d 7, the peripheral leukocyte number decreased on d9 and recovered to normal level about d13 to d15. Such recovery was accelerated by administrating PAP-1, 10mg/kg, 3 times/wk. A significant increase of the activity to form colony in spleen(colony-forming unit in spleen, CFU-S_(8), CUF-S_(12))in mice irradiated with 550 rad ~(Co) gamma-rays and an enhancement of proliferative response of BMC to rmGM-CSF treated with PAP-1, 10mg/kg, 3 times/wk, ip were observed. After PAP-1, 10mg/kg, ip once, a significant increase in the number of peripheral blood leukocytes and a rise in the serum of colony stimulating factor (CSF) were also confirmed. The types of CSF in serum were M-CSF and other hematopoietic growth factors, which were confirmed by using McAb of IL-3, GM-CSF and PcAb of M-CSF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Average survival time of mice treated with cyclophosphamide (CY)300mg/kg once alone was 13.3±7.2d(n=7), however, averge survival time of mice treated with CY 300 mg/kg in combination with PAP-1,10mg/kg, 3time/wk was 36.7±16.4d(n=7,P<0.01). PAP-1, ip had beneficial effect on the recovery of the CY induced decrease of peripheral leukocyte number, and the nucleated bone marrow cell (BMC) number and [~(3)H]TdR uptaken by BMC induced by rmGM-CSF in S180 bearing mice treated with CY, In mice, after the first ip treatment with CY 100mg/kg on d 7, the peripheral leukocyte number decreased on d9 and recovered to normal level about d13 to d15. Such recovery was accelerated by administrating PAP-1, 10mg/kg, 3 times/wk. A significant increase of the activity to form colony in spleen(colony-forming unit in spleen, CFU-S_(8), CUF-S_(12))in mice irradiated with 550 rad ~(Co) gamma-rays and an enhancement of proliferative response of BMC to rmGM-CSF treated with PAP-1, 10mg/kg, 3 times/wk, ip were observed. After PAP-1, 10mg/kg, ip once, a significant increase in the number of peripheral blood leukocytes and a rise in the serum of colony stimulating factor (CSF) were also confirmed. The types of CSF in serum were M-CSF and other hematopoietic growth factors, which were confirmed by using McAb of IL-3, GM-CSF and PcAb of M-CSF.

Key concepts: Haematopoiesis, Cyclophosphamide, Bone marrow, Spleen, Peripheral blood, Andrology, Biology, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Protective effect of Phytolacca acinosa polysaccharides I (PAP-I) on hematopoiesis in cyclophosphamide-treated and ~(6))Co-irradiated mice — Research Paper | ScholarLens